Skip to main content
China Legal Guides · National framework

Biotech Trade Secrets & Non-Competes in China: Pipeline Leakage, R&D Exits & Criminal Overlays

The highest-value biotech asset is often not a granted patent—it is the unfinished pipeline, process know-how, and negative data in scientists’ heads and laptops. Exit events and vendor sprawl are where secrets leak.

Updated16 Aug 2026
AudienceForeign businesses & individuals
Author Rui Tang · Reviewer Jinrong Zhou · Last reviewed · 3 min read · Editorial policy · AI content policy · Disclaimer · Not legal advice — confirm current rules with counsel and authorities

At a glance

Workflow in this guide

Section sequence for this topic.

  1. What to protect (beyond “confidential” stamps)
  2. R&D director / scientist exit protocol
  3. Non-compete (竞业限制) economics
  4. Civil claim themes
  5. Criminal overlay
  6. Device software & drawings
Legal planning desk with source documents, authority records and evidence file
Working file · authority, workflow and evidence
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, and clinical trial regimes. Facts, licences, and enforcement practice change. This is not legal advice and does not create an attorney–client relationship. Instruct qualified PRC counsel (and foreign counsel where FDA/EMA/CFIUS paths apply) before you recall product, transfer samples, answer a raid, or file a patent challenge.

Life sciences & healthcare legal cluster: Hub · Dawn raid · VBP · Hospital AR · Exclusive agency · HGR · Trial injury · CRO/CDMO · Device liability · Labeling · SaMD · Patent linkage · License · FDA WL · MDR/IVDR · Internet hospital · Trade secrets · Pharma ads · Device distribution · Sources · Checklist

What to protect (beyond “confidential” stamps)

  • Molecule/process recipes, cell-line genealogy, formulation and scale-up parameters.
  • Clinical and nonclinical datasets, protocol design choices, and failed experiments.
  • Device source code, hardware drawings, and verification protocols.
  • Customer hospital lists and tender pricing models where secrecy is maintained in fact—not only on paper.

R&D director / scientist exit protocol

  • Trigger access cut-off the day notice is given—not after the farewell dinner.
  • Forensic image of assigned devices; preserve cloud drive and enterprise chat under counsel direction.
  • Inventory notebooks, cell banks, and USB exceptions; obtain written certifications of return.
  • Interview teammates on unusual downloads or “personal project” transfers in the prior 90 days.
  • Compare new employer’s pipeline announcements to your secret set—without illegal competitive intelligence methods.

Non-compete (竞业限制) economics

Post-employment non-competes for key R&D staff are only as strong as statutory form, compensation practice, and scope reasonableness. Underpay or overbroad geography/job scope and enforcement weakens. Align non-compete design with garden-leave options and trade-secret injunction strategy—non-compete is not a substitute for secrecy hygiene.

Civil claim themes

  • Prove secrecy measures (access control, NDAs, compartmentalisation)—stamps alone fail.
  • Prove defendant obtained and used the secret (source code diff, process fingerprint, customer conversion timeline).
  • Damages models: R&D cost, unjust enrichment, or licence analogy—document valuation early.
  • Preliminary measures to stop ongoing use while the case proceeds.

Criminal overlay

Serious trade-secret theft can engage public-security tracks when thresholds and intent align. Dual-track strategy needs careful sequencing so criminal filing does not destroy civil evidence control—or vice versa. Coordinate with specialised IP counsel before any public accusation.

Device software & drawings

Source code and hardware drawings often sit at the intersection of copyright, trade secret, and patent. Appraisal institutes and reverse-engineering experts become critical. Keep build servers and Git history under company control with named accounts—no shared “admin” logins.

Vendor & CRO leakage

CDMO/CRO staff and seconded consultants are frequent vectors. Flow-down secrecy, audit rights, and hire-away clauses in CRO/CDMO contracts; pair with licence data rooms that watermark and log downloads.

Patent linkage · Trade-secret practice pages on this site · Hub

FAQ · 高频检索问题

Chinese long-tail intents mapped to this guide (orientation only).

研发总监跳槽带走管线如何立案?
Preserve devices and access logs immediately, document secrecy measures, and instruct counsel on civil injunction plus possible criminal referral—do not confront with illegal self-help.
竞业限制补偿金怎么定才有效?
Follow statutory and judicial practice on amount, payment method, and duration; unpaid compensation undermines enforceability. Tailor scope to real competitive roles.
源代码侵权如何鉴定?
Use chain-of-custody for code bases, trusted appraisal routes, and compare unique non-public implementations—not only open-source overlap.

Need sector counsel?

Map your issue to a specialty desk: Life sciences & healthcare · Devices & IVD · Clinical & health data · Product liability · Industry hub.

Find counsel
Legal source archive with indexed legislation and official records
Source register · primary authorities and verification
Sources & trust

How to use this guide

Primary sources cited on this page: Molecule/process recipes, cell-line genealogy, formulation and scale-up parameters.; Clinical and nonclinical datasets, protocol design choices, and failed experiments.; Device source code, hardware drawings, and verification protocols.; Customer hospital lists and tender pricing models where secrecy is maintained in fact�not only on paper.; Trigger access cut-off the day notice is given�not after the farewell dinner.; Forensic image of assigned devices; preserve cloud drive and enterprise chat under counsel direction.; Inventory notebooks, cell banks, and USB exceptions; obtain written certifications of return.; Interview teammates on unusual downloads or �personal project� transfers in the prior 90 days.; Compare new employer�s pipeline announcements to your secret set�without illegal competitive intelligence methods.; Prove secrecy measures (access control, NDAs, compartmentalisation)�stamps alone fail.; Prove defendant obtained and used the secret (source code diff, process fingerprint, customer conversion timeline).; Damages models: R&D cost, unjust enrichment, or licence analogy�document valuation early..

Editorial, AI and verification policies

This page is general information for orientation. It is not legal advice and does not create an attorney–client relationship.

Review the Editorial Policy, AI Content Policy, and Lawyer Verification Policy.

Consultation preparation

Before contacting counsel

First package for a conflict check
  • A concise timeline and the result you want to achieve.
  • Names of all parties and affiliates for a conflict check.
  • Key contracts, notices, correspondence, filings, or decisions.
  • Known deadlines, preferred language, location, and budget constraints.
City hubs

Intellectual Property in major cities

City pages for this practice area.

Directory

Intellectual Property lawyer profiles

China-based listings shown first. Review profiles for intellectual property, then submit an initial enquiry.

Status shown per profileFree initial intakeChina-first directory sort

Need counsel on intellectual property?

Review listed lawyer profiles and submit an initial enquiry. No obligation.